| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 784 | 702 | 744 | 1,029 | | Cost of Revenue | 515 | 528 | 1,151 | 602 | | | Gross Profit | 269 | 173 | (407) | 427 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 276 | 509 | 835 | 607 | | Non Recurring | 777 |
-
|
-
|
-
| | Others | 695 | 722 | 2,251 | 454 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,479) | (1,058) | (3,493) | (634) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (90) | 14 | 156 | 5 | | Earnings Before Interest And Taxes | (1,569) | (1,044) | (3,544) | (629) | | Interest Expense |
-
|
-
|
-
| 1 | | Income Before Tax | (1,569) | (1,044) | (3,544) | (630) | | Income Tax Expense | (352) | (340) | (873) | (220) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,217) | (704) | (2,670) | (410) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,217) | (704) | (2,670) | (410) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,217) | ($704) | ($2,670) | ($410) |
|
0.21% Nasdaq 
0.04%
Income Statement
